Physician profile
Lisa Miller
NPI 1285637355
$1,245.65
in general payments reported to CMS, 2019-2025
19 companies · $368 in 2025
The $368 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.92 · 2020: $17.91 · 2022: $112 · 2023: $301 · 2024: $378 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $267.78 | 2023-2025 | Azstarys |
| Cranial Technologies, INC | $157.78 | 2022-2025 | Doc Band |
| Verrica Pharmaceuticals INC. | $146.94 | 2024 | Ycanth |
| Sanofi-Aventis U.S. LLC | $139.58 | 2023-2025 | |
| Glaxosmithkline, LLC. | $121.79 | 2022-2025 | Bexsero |
| Pfizer INC. | $78.29 | 2019-2024 | |
| Genentech USA, INC. | $53.80 | 2019-2020 | |
| Tris Pharma INC | $52.89 | 2019-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $37.10 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $30.12 | 2022-2023 | Vaxneuvance, Gardasil 9, M-M-R II |
| Astrazeneca Pharmaceuticals LP | $23.09 | 2023 | Flumist Quadrivalent |
| Organon LLC | $20.63 | 2025 | |
| Meridian Bioscience INC. | $20.01 | 2024 | |
| Alk-Abello, INC | $19.56 | 2025 | Neffy, Odactra, Grastek |
| Neos Therapeutics, LP | $16.05 | 2024 | Adzenys Xr-Odt |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $15.98 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.38 | 2025 | Zoryve |
| Ars Pharmaceuticals Operations, INC. | $14.65 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $14.23 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.